Physician

Abdul R H Mamsa, M.D

According to 2025 Medicare claims, Abdul Mamsa, M.D (NPI: 1871764241) practices neurology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Osceola, FL. This provider's primary affiliated billing organization is NEUROLOGY CONSULTANTS OF CENTRAL FLORIDA INC (NPI: 1598821340; TIN: 59-3191744) and primary practice location at 34741-6625.

Mamsa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 258 traditional Medicare patients, billed 616 HCPCS/CPT codes, and received $44,444 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,601 prescription claims across 353 beneficiaries totaling $812,261 in drug costs, led by Gammaked (Immune Globul G/Gly/Iga Avg 46). 2022 DME data shows 33 claims. Open Payments data shows 18 records totaling $523. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $144,491 to $44,444. Similarly, Part D prescription costs have declined steadily, from $861,493 to $812,261. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	600	1,724	$144,491
2016	526	1,401	$97,977
2017	406	993	$75,237
2018	467	958	$87,665
2019	590	1,600	$140,402
2020	450	1,138	$98,919
2021	364	840	$76,887
2022	291	627	$54,229
2023	218	503	$36,407
2024	258	616	$44,444

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	350	2,933	$861,493
2016	385	3,144	$1,253,893
2017	362	2,925	$1,658,476
2018	311	2,442	$1,553,745
2019	352	2,318	$1,170,936
2020	313	2,288	$1,030,749
2021	293	2,260	$876,504
2022	313	2,372	$1,013,240
2023	300	2,134	$831,001
2024	353	2,601	$812,261

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	33	$2,235
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	68	69	$135
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	48	48	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	120	236	$65
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	75	134	$61
95812	Measurement of brain wave activity (eeg), 41-60 minutes	63	70	$43

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gammaked	Immune Globul G/Gly/Iga Avg 46	14	402	$281,739
Rebif Rebidose	Interferon Beta-1a/Albumin	14	392	$144,914
Copaxone	Glatiramer Acetate	12	360	$87,046
Briviact	Brivaracetam	12	360	$19,992
Vimpat	Lacosamide	11	330	$8,051

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$523	UCB, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdul R. H. Mamsa, M.D?

Tedicare shows public-source Medicare data for Abdul R. H. Mamsa, M.D (NPI 1871764241), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul R. H. Mamsa, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abdul R. H. Mamsa, M.D?

Abdul R. H. Mamsa, M.D is linked to NEUROLOGY CONSULTANTS OF CENTRAL FLORIDA INC (billing NPI 1598821340) in the available physician profile data.

Does Abdul R. H. Mamsa, M.D have Open Payments data?

Abdul R. H. Mamsa, M.D has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.